178 related articles for article (PubMed ID: 17440966)
21. Increased expression and activity of CDC25C phosphatase and an alternatively spliced variant in prostate cancer.
Ozen M; Ittmann M
Clin Cancer Res; 2005 Jul; 11(13):4701-6. PubMed ID: 16000564
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of cholesterol and phytosterols on cell proliferation, apoptosis and expression of a prostate specific gene in prostate cancer cell lines.
Ifere GO; Barr E; Equan A; Gordon K; Singh UP; Chaudhary J; Igietseme JU; Ananaba GA
Cancer Detect Prev; 2009; 32(4):319-28. PubMed ID: 19186008
[TBL] [Abstract][Full Text] [Related]
23. [Construction of a eukaryotic vector expressing E2F-1 Gene and its effect on proliferation of gastric cancer cell line MKN-45].
Wang CQ; Xiao Q; Li L; Xie YB; Tan N; Gong ZW
Ai Zheng; 2007 Oct; 26(10):1064-8. PubMed ID: 17927874
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide characterization of gene expression variations and DNA copy number changes in prostate cancer cell lines.
Zhao H; Kim Y; Wang P; Lapointe J; Tibshirani R; Pollack JR; Brooks JD
Prostate; 2005 May; 63(2):187-97. PubMed ID: 15486987
[TBL] [Abstract][Full Text] [Related]
25. DNA microarray analysis reveals metastasis-associated genes in rat prostate cancer cell lines.
Reyes I; Tiwari R; Geliebter J; Reyes N
Biomedica; 2007 Jun; 27(2):190-203. PubMed ID: 17713630
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
27. Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase.
Shao C; Wang Y; Yue HH; Zhang YT; Shi CH; Liu F; Bao TY; Yang ZY; Yuan JL; Shao GX
J Androl; 2007; 28(6):804-12. PubMed ID: 17581945
[TBL] [Abstract][Full Text] [Related]
28. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas.
Zacharatos P; Kotsinas A; Evangelou K; Karakaidos P; Vassiliou LV; Rezaei N; Kyroudi A; Kittas C; Patsouris E; Papavassiliou AG; Gorgoulis VG
J Pathol; 2004 Jul; 203(3):744-53. PubMed ID: 15221933
[TBL] [Abstract][Full Text] [Related]
29. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array.
Dong Y; Zhang H; Hawthorn L; Ganther HE; Ip C
Cancer Res; 2003 Jan; 63(1):52-9. PubMed ID: 12517777
[TBL] [Abstract][Full Text] [Related]
30. Gene expression of survivin and its spliced isoforms associated with proliferation and aggressive phenotypes of prostate cancer.
Koike H; Sekine Y; Kamiya M; Nakazato H; Suzuki K
Urology; 2008 Dec; 72(6):1229-33. PubMed ID: 18336887
[TBL] [Abstract][Full Text] [Related]
31. KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.
Lee MY; Moon JS; Park SW; Koh YK; Ahn YH; Kim KS
Biochem J; 2009 Jan; 417(1):313-22. PubMed ID: 18774944
[TBL] [Abstract][Full Text] [Related]
32. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells.
Xu J; Gao M; Fan S; Meng Q; Goldberg ID; Abounader R; Ressom H; Laterra JJ; Rosen EM
Oncogene; 2007 May; 26(20):2925-38. PubMed ID: 17099727
[TBL] [Abstract][Full Text] [Related]
33. The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.
Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
Oncol Rep; 2005 May; 13(5):983-8. PubMed ID: 15809768
[TBL] [Abstract][Full Text] [Related]
34. [Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
Deng G; Yu JH; Ye ZQ; Hu ZQ
Zhonghua Nan Ke Xue; 2008 Feb; 14(2):116-21. PubMed ID: 18390174
[TBL] [Abstract][Full Text] [Related]
35. PTOV1: a novel testosterone-induced atherogenic gene in human aorta.
Nakamura Y; Suzuki T; Igarashi K; Kanno J; Furukawa T; Tazawa C; Fujishima F; Miura I; Ando T; Moriyama N; Moriya T; Saito H; Yamada S; Sasano H
J Pathol; 2006 Aug; 209(4):522-31. PubMed ID: 16639697
[TBL] [Abstract][Full Text] [Related]
36. Aspirin enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in hormone-refractory prostate cancer cells through survivin down-regulation.
Yoo J; Lee YJ
Mol Pharmacol; 2007 Dec; 72(6):1586-92. PubMed ID: 17848598
[TBL] [Abstract][Full Text] [Related]
37. The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells.
Arai M; Kondoh N; Imazeki N; Hada A; Hatsuse K; Matsubara O; Yamamoto M
Liver Int; 2009 Jan; 29(1):55-62. PubMed ID: 18492021
[TBL] [Abstract][Full Text] [Related]
38. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas.
De Meyer T; Bijsmans IT; Van de Vijver KK; Bekaert S; Oosting J; Van Criekinge W; van Engeland M; Sieben NL
J Pathol; 2009 Jan; 217(1):14-20. PubMed ID: 18991331
[TBL] [Abstract][Full Text] [Related]
39. DNMT1 silencing affects locus specific DNA methylation and increases prostate cancer derived PC3 cell invasiveness.
Yaqinuddin A; Qureshi SA; Qazi R; Farooq S; Abbas F
J Urol; 2009 Aug; 182(2):756-61. PubMed ID: 19539327
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
